SCHEMBL24683711

SCHEMBL24683711

CC1Cc2ncn(C(C)C)c2C(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21698783 0.67 POLB (0.37) —
SCHEMBL18762256 0.64 ADORA2A (0.32) —
SCHEMBL18762232 0.60 ADORA2A (0.32) —
SCHEMBL22326702 0.58 — —
SCHEMBL17380063 0.58 ADORA2A (0.32) —
SCHEMBL17338953 0.57 ADORA2A (0.32) —
SCHEMBL17338950 0.57 ADORA2A (0.32) —
SCHEMBL17678380 0.57 ADORA2A (0.31) —
SCHEMBL15723732 0.57 PDE3B (0.33) —
SCHEMBL24328037 0.56 CYP11B2 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315584-A1 1H-IMIDAZO[4,5-H]QUINAZOLINE COMPOUND AS PROTEIN KINASE INHIBITOR SHENGKE PHARMACEUTICALS (JIANGSU) LTD. (CN) 2022-10-06 — — US disclosed
Send feedback